Abstract 368: Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy

Introduction. Intensive induction chemotherapy in non-M3 young Acute Myeloid Leukemia (AML) patients is represented by the association of an antracycline and Cytarabine. Some treatment regimens including fludarabine or the addition of Gemtuzumab Ozogamicin (GO) as a third or fourth drug, proved to g...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 2016-07, Vol.76 (14_Supplement), p.368-368
Hauptverfasser:	Papayannidis, Cristina, Fontana, Maria Chiara, Marconi, Giovanni, Guadagnuolo, Viviana, Simonetti, Giorgia, Padella, Antonella, Soverini, Simona, Paolini, Stefania, Abbenante, Maria Chiara, Parisi, Sarah, Sartor, Chiara, Lo Monaco, Silvia, Manfrini, Marco, Zuffa, Elisa, Franchini, Eugenia, Venturi, Claudia, Bochicchio, Maria Teresa, Ghelli Luserna di Rorà, Andrea, Ottaviani, Emanuela, Martinelli, Giovanni
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!